The US dermatology OTC medications market was valued at US$ 952.97 million in 2020 and is projected to reach US$ 1,124.56 million by 2028; it is expected to grow at a CAGR of 2.1% during 2021–2028.
The growth of the market is attributed to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). However, the side effects associated with OTC dermatology medication such as skin allergy hinder the growth of the market.
The US dermatology OTC medications market is expected to witness significant growth during the forecast period. The growth of the market is expected to be fastest due to rising prevalence of skin abnormalities and increasing availability of dermatology medication over the counter (OTC). For instance, as per to the American Academy of Dermatology Association, acne is the most common skin condition in the US, affecting ~50 million Americans annually. ~85% of people from the age group of 12–24 experience minor acne problems. Additionally, the COVID-19 has affected a large population in the US leading to an unprecedented surge in demand for popular OTC drugs. Consumers appear to be trying to address illness symptoms on their own, to avoid visiting clinic. Physical distancing and stay-at-home orders have forced consumer to shop differently. Also, continuous use of mask and constant handwashing has led to skin irritation, and maskne. Constant handwashing has led to increase in conditions such as skin dryness and eczema, this has led to increase in demand for dermatology OTC products.
US Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
US Dermatology OTC Medications Market Segmentation
By Product Type
- Tablets and Capsules
- Oils
- Gels
- Creams and Ointments
- Others
By Indication
- Dermatitis
- Acne
- Psoriasis
- Skin Bleaching
- Anti-Fungal
- Wart Remover
- Others
By Route of Administration
- Topical
- Oral
By Distribution Channel
- Online Distribution
- Hospital and Retail Pharmacies
- Super and Hyper Markets
Company Profiles
- Bausch Health Companies Inc
- Perrigo Company Plc
- Bayer AG
- Viatris Inc.
- Johnson and Johnson Services, Inc.
- LEO Pharma A/S
- GlaxoSmithKline Plc.
- Galderma
- Dr. Reddy's Laboratories
- Acella Pharmaceuticals, LLC
US Dermatology OTC Medications Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 952.97 Million |
| Market Size by 2028 | US$ 1,124.56 Million |
| Global CAGR (2021 - 2028) | 2.1% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | United State
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - US Dermatology OTC Medications Market
- Bausch Health Companies Inc
- Perrigo Company Plc
- Bayer AG
- Viatris Inc.
- Johnson and Johnson Services, Inc.
- LEO Pharma A/S
- GlaxoSmithKline Plc.
- Galderma
- Dr. Reddy's Laboratories
- Acella Pharmaceuticals, LLC
Get Free Sample For